Position in JNJ
as of Jun 30, 2026
· filed Aug 18, 2026
Position Value
$92,863,622
+$3,325,984 QoQ
Shares Held
365,648
-0.2% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
1.01%
of 13F equity value
Holder Rank
#316
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Derivatives in JNJ
reported options exposure · as of Jun 30, 2025CallValue
$229,125
CallShares
1,500
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Beacon Pointe Advisors, LLC holds $381,609,244 across 14 Drug Manufacturers - General names. JNJ ranks #1 (24.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
365,648 | $92,863,622 | |
| 2 | LLY |
ELI LILLY & Co
|
61,241 | $73,454,298 | |
| 3 | ABBV |
AbbVie Inc.
|
195,761 | $49,261,298 | |
| 4 | MRK |
Merck & Co., Inc.
|
363,066 | $46,653,981 | |
| 5 | AMGN |
Amgen Inc
|
108,053 | $39,128,152 | |
| 6 | PFE |
Pfizer Inc
|
1,161,607 | $27,971,496 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
232,697 | $13,408,001 | |
| 8 | NVS |
Novartis AG
|
84,234 | $13,201,152 |
All Filings in JNJ
Export CSV
28 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $92,863,622 | 365,648 | Shares | Sole | 2026-08-18 | |
| 2026-03-31 | $89,537,638 | 366,297 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $55,335,739 | 267,387 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $49,531,059 | 267,129 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $43,870,105 | 287,202 | Shares | Sole | 2025-08-13 | |
| 2025-06-30 | $229,125 | 1,500 | Call | Sole | 2025-08-13 | |
| 2025-03-31 | $248,760 | 1,500 | Call | Sole | 2025-05-13 | |
| 2025-03-31 | $52,540,267 | 316,813 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $38,928,377 | 269,177 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $45,543,073 | 281,026 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $42,971,770 | 294,005 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $53,303,069 | 336,956 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $55,645,834 | 355,020 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $57,029,575 | 366,161 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $44,353,235 | 267,963 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $45,192,265 | 291,563 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $48,209,728 | 272,911 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $44,307,969 | 271,229 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $49,680,078 | 279,872 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $66,590,805 | 375,731 | Shares | Sole | 2022-05-17 | |
| 2021-12-31 | $22,124,825 | 129,332 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $31,762,689 | 196,673 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $13,882,310 | 84,268 | Shares | Sole | 2021-08-17 | |
| 2021-03-31 | $5,915,449 | 35,993 | Shares | Sole | 2021-05-18 | |
| 2020-12-31 | $5,794,102 | 36,816 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $4,215,239 | 28,313 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $4,319,309 | 30,714 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $3,408,593 | 25,994 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||